Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004-05 study (Q83660318)
Jump to navigation
Jump to search
scientific article published on 17 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004-05 study |
scientific article published on 17 March 2011 |
Statements
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004-05 study (English)
M Martín
P Sánchez-Rovira
M Muñoz
J M Baena-Cañada
J R Mel
M Margeli
M Ramos
E Martínez
A Casado
A M Jaén
M J Escudero
C Rodriguez-Martin
E Carrasco
17 March 2011